Emerging Lab-on-a-Chip Approaches for Liquid Biopsy in Lung Cancer: Status in CTCs and ctDNA Research and Clinical Validation

SIMPLE SUMMARY: Lung cancer (LCa) remains the leading cause of cancer-related mortality worldwide, with late diagnosis and limited therapeutic approaches still constraining patient’s outcome. In recent years, liquid biopsies have significantly improved the disease characterization and brought new in...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvalho, Ângela, Ferreira, Gabriela, Seixas, Duarte, Guimarães-Teixeira, Catarina, Henrique, Rui, Monteiro, Fernando J., Jerónimo, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123575/
https://www.ncbi.nlm.nih.gov/pubmed/33925308
http://dx.doi.org/10.3390/cancers13092101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123575/
https://www.ncbi.nlm.nih.gov/pubmed/33925308
http://dx.doi.org/10.3390/cancers13092101

Ejemplares similares